Literature DB >> 8970971

A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.

S Moffatt1, N Tanaka, K Tada, M Nose, M Nakamura, O Muraoka, T Hirano, K Sugamura.   

Abstract

We examined the biological function of a nonstructural regulatory protein, NS1, of human parvovirus B19. Because of the cytotoxic activity of NS1, human hematopoietic cell lines, K562, Raji, and THP-1, were established as transfectants which produce the viral NS1 protein upon induction by using bacterial lactose repressor/operator system. NS1 was significantly produced in the three transfectant cells in an inducer dose- and time-dependent manner. Surprisingly, these three transfectants secreted an inflammatory cytokine, interleukin-6 (IL-6), in response to induction. However, no production of other related cytokines, IL-1beta, IL-8, or tumor necrosis factor alpha, was seen. Moreover, NS1-primed IL-6 induction was transiently demonstrated in primary human endothelial cells. Analysis with luciferase reporter plasmids carrying IL-6 promoter mutant fragments demonstrated that NS1 effect is mediated by a NF-kappaB binding site in the IL-6 promoter region, strongly implying that NS1 functions as a trans-acting transcriptional activator on the IL-6 promoter. Our novel finding, IL-6 induction by NS1, supports the possible relationship between parvovirus B19 infection and polyclonal activation of B cells in rheumatoid arthritis and indicates that NS1 protein may play a significant role in the pathogenesis of some B19-associated diseases by modulating the expression of host cellular genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970971      PMCID: PMC190939     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.

Authors:  K Yoshimoto; S Rosenfeld; N Frickhofen; D Kennedy; R Hills; S Kajigaya; N S Young
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.

Authors:  G Kurtzman; N Frickhofen; J Kimball; D W Jenkins; A W Nienhuis; N S Young
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

3.  Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.

Authors:  J E Green; S H Hinrichs; J Vogel; G Jay
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

4.  A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside.

Authors:  S B Baim; M A Labow; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 5.  Biological and clinical aspects of interleukin 6.

Authors:  T Hirano; S Akira; T Taga; T Kishimoto
Journal:  Immunol Today       Date:  1990-12

6.  Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins.

Authors:  P Caillet-Fauquet; M Perros; A Brandenburger; P Spegelaere; J Rommelaere
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

7.  Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

Authors:  Y Iwakura; M Tosu; E Yoshida; M Takiguchi; K Sato; I Kitajima; K Nishioka; K Yamamoto; T Takeda; M Hatanaka
Journal:  Science       Date:  1991-08-30       Impact factor: 47.728

8.  Interleukin-6 gene expression in Castleman's disease.

Authors:  M B Leger-Ravet; M Peuchmaur; O Devergne; J Audouin; M Raphael; J Van Damme; P Galanaud; J Diebold; D Emilie
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

9.  Regulation of synovial cell proliferation and prostaglandin E2 production by combined action of cytokines.

Authors:  C Jorgensen; J Angel; C Fournier
Journal:  Eur Cytokine Netw       Date:  1991 May-Jun       Impact factor: 2.737

10.  Expression of minute virus of mice major nonstructural protein in insect cells: purification and identification of ATPase and helicase activities.

Authors:  G M Wilson; H K Jindal; D E Yeung; W Chen; C R Astell
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  44 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Chronic hepatitis caused by persistent parvovirus B19 infection.

Authors:  Trine H Mogensen; Jens Magnus B Jensen; Stephen Hamilton-Dutoit; Carsten S Larsen
Journal:  BMC Infect Dis       Date:  2010-08-20       Impact factor: 3.090

Review 3.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

4.  The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA.

Authors:  Sunil Kumar Tewary; Haiyan Zhao; Xuefeng Deng; Jianming Qiu; Liang Tang
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

5.  Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation.

Authors:  Kenji Abe; Tetsuya Kiuchi; Koichi Tanaka; Yoshihiro Edamoto; Naoto Aiba; Tetsutaro Sata
Journal:  Int J Med Sci       Date:  2007-04-05       Impact factor: 3.738

6.  Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.

Authors:  Thomas A O'Bryan; Stanley J Naides
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

7.  Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice.

Authors:  J C Segovia; J M Gallego; J A Bueren; J M Almendral
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.

Authors:  Loris Pironi; Francesca Bonvicini; Paolo Gionchetti; Antonia D'Errico; Fernando Rizzello; Catia Corsini; Laura Foroni; Giorgio Gallinella
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

9.  The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.

Authors:  Xuefeng Deng; Yanming Dong; Qianhui Yi; Yu Huang; Dan Zhao; Yongbo Yang; Peter Tijssen; Jianming Qiu; Kaiyu Liu; Yi Li
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Structure of the NS1 protein N-terminal origin recognition/nickase domain from the emerging human bocavirus.

Authors:  Sunil Kumar Tewary; Haiyan Zhao; Weiran Shen; Jianming Qiu; Liang Tang
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.